ZM522 is a CD73 inhibitor with an IC 50 value of 0.56 μM. ZM522 effectively increases the levels of interferon-γ ( INF-γ ) and enhances immune activity by regulating the activation status of T cells. ZM522 holds promise for research in the fields of immunology and cancer therapy.